NORCAT is pleased to announce the official approval from the Chief Prevention Officer to deliver the new mandatory Working at Heights training program.
The Working at Heights, full day program is designed to provide instruction to any worker who is regularly, or on occasion, assigned work that may require working at heights criteria whereby fall arrest protection equipment and safeguards are required to be implemented.
With successful completion of the training, the trainee will know: the governing rules and regulations; the responsibilities of the worker, supervisor and employer; the various types of devices available and their use; how to inspect and use harnesses, lanyards and anchors and understand rescue plans. The training session will be a combination of theory and practical instruction. Read more ►
RNA Diagnostics, a Sudbury-based medical diagnostic company, has successfully closed an additional round of angel investment with support of the NORCAT Innovation Mill Angel group.
RNA Diagnostics, with their patented RNA Disruption Assay™ (RDA™), enables clinicians to identify patients who are not responding to chemotherapy early during treatment. Patients who are not responding can be switched quickly to alternate therapies, thereby avoiding unnecessary toxic side effects and improving their survival chances. Read more ►